FDC trades higher on the BSE
FDC is currently trading at Rs. 285.40, up by 4.45 points or 1.58% from its previous closing of Rs. 280.95 on the BSE.
The scrip opened at Rs. 282.40 and has touched a high and low of Rs. 285.40 and Rs. 281.05 respectively. So far 8329 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 323.15 on 13-Jan-2022 and a 52 week low of Rs. 229.15 on 24-Jun-2022.
Last one week high and low of the scrip stood at Rs. 286.60 and Rs. 276.55 respectively. The current market cap of the company is Rs. 4685.30 crore.
The promoters holding in the company stood at 69.49%, while Institutions and Non-Institutions held 10.76% and 19.75% respectively.
FDC’s flagship brand -- ZIFI has been awarded with Certificate of Excellence for Brand of the Year 2022 (2nd Runner Up) in Acute Therapy between 500-2000 Crores Corporates at AWACS 2022.
Further, FAVENZA was recognized for New Introduction of the Year in Acute Therapy between 500-2000 Crores Corporates.
FDC made a modest beginning with marketing of vitamins and a range of prescription formulations. The company subsequently set up their formulations manufacturing facility and also pioneered the manufacture of specialized ophthalmic formulations in India.